Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2019.4101
Abstract: Importance Bioresorbable scaffolds were designed to provide clinical benefits after their complete bioresorption. Prior studies demonstrated early risks with the Absorb polymeric bioresorbable vascular scaffold (BVS). Whether this risk profile changes over time during the… read more here.
Keywords: analysis; year follow; treated patients; bioresorbable vascular ... See more keywords
HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of hematology"
DOI: 10.1002/ajh.26627
Abstract: The best stem cell source for T-cell replete HLA-haploidentical transplantation with post-transplant cyclophosphamide (PTCy) remains to be determined. In this EBMT retrospective study we analyzed the impact of stem cell source on leukemia-free survival (LFS)… read more here.
Keywords: patients years; hla haploidentical; years age; haploidentical transplantation ... See more keywords
Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-019-02298-9
Abstract: BackgroundCheckpoint inhibitors are first-line therapies in melanoma, but safety in older adults has not yet been assessed. Ipilimumab improves survival, but immunologic-related adverse events (AEs) can be threatening, and its use in elderly people raises… read more here.
Keywords: melanoma; treated ipilimumab; elderly patients; years treated ... See more keywords
The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-019-03895-2
Abstract: To evaluate the efficacy and safety of nab paclitaxel (nab-P) plus gemcitabine (GEM) in elderly patients ≥ 75 years old with unresectable pancreatic cancer (PC) compared with younger patients. The data of 27 unresectable PC… read more here.
Keywords: efficacy safety; group; safety nab; elderly patients ... See more keywords
Clinical effectiveness and adverse events associated with tolvaptan in patients above 90 years of age with acute decompensated heart failure
Sign Up to like & getrecommendations! Published in 2021 at "Heart and Vessels"
DOI: 10.1007/s00380-020-01753-3
Abstract: With the aging society, the number of very-elderly (VE) patients with acute decompensated heart failure (ADHF) is increasing. Although tolvaptan is recommended for patients with ADHF in whom conventional diuretic therapy is ineffective, few reports… read more here.
Keywords: age; years age; group; nve group ... See more keywords
Surgical outcomes of laparoscopic distal pancreatectomy in elderly and octogenarian patients: a single-center, comparative study
Sign Up to like & getrecommendations! Published in 2018 at "Surgical Endoscopy"
DOI: 10.1007/s00464-018-6489-1
Abstract: BackgroundAlthough recent reports have suggested the advantages of laparoscopic distal pancreatectomy (LDP), the potential benefits of this approach in elderly patients remain unclear. The aim of this study was to clarify the value of LDP… read more here.
Keywords: laparoscopic distal; distal pancreatectomy; study; elderly patients ... See more keywords
Dealing with rhegmatogenous retinal detachment in patients under 40 years old: a tertiary center results
Sign Up to like & getrecommendations! Published in 2020 at "International Ophthalmology"
DOI: 10.1007/s10792-020-01597-w
Abstract: The risk of rhegmatogenous retinal detachment (RRD) increases with age, but some studies report a secondary peak in younger patients. Since visual recovery in RRD depends on surgical treatment and, considering the personal, social and… read more here.
Keywords: rhegmatogenous retinal; years old; retinal detachment; patients years ... See more keywords
Shift Towards Older Bariatric Patients
Sign Up to like & getrecommendations! Published in 2017 at "Obesity Surgery"
DOI: 10.1007/s11695-017-3039-1
Abstract: There is an ongoing shift in the age distribution of bariatric patients. This assumption was confirmed in a large bariatric center with a retrospective analysis of primary operations. Before 2008, 28% of the patients were… read more here.
Keywords: age; bariatric patients; obesity; older patients ... See more keywords
Predictors of early failure of the cannulated screw system in patients, 65 years and older, with non-displaced femoral neck fractures
Sign Up to like & getrecommendations! Published in 2019 at "Aging Clinical and Experimental Research"
DOI: 10.1007/s40520-019-01394-1
Abstract: Background Hip fractures represent the most common injury and the main cause of morbidity and mortality among patients 65 years and older. About 20% of all femoral neck fractures (FNFs) are non-displaced or valgus impacted, for… read more here.
Keywords: years older; posterior tilt; early failure; failure ... See more keywords
Influence of frailty in the outcome of surgical patients over 70 years old with admission criteria in ICU
Sign Up to like & getrecommendations! Published in 2021 at "Cirugia Espanola"
DOI: 10.1016/j.cireng.2020.12.011
Abstract: Abstract Introduction Frailty degree can influence more than age or severity in the outcome of patients older than 70 years undergoing surgery of the digestive system that require immediate postoperative control in the ICU. Methods… read more here.
Keywords: outcome; influence frailty; mfi; frailty ... See more keywords
Myelodysplastic syndromes and acute myeloid leukemias in the elderly.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2018.05.026
Abstract: Most patients above 60 years with acute myeloid leukemia (AML) will die from their disease. Nevertheless, the treatment concepts in elderly patients with myelodysplastic syndromes (MDS) and AML are rapidly evolving. A number of recent reports… read more here.
Keywords: myelodysplastic syndromes; aml patients; treatment; acute myeloid ... See more keywords